P2RX7 and acute myeloid leukemia: Interestingly, P2X7 receptor activation also makes AML cells more resistant to chemotherapy medicines; the likelihood of chemotherapeutic medications entering the cell is increased when non-selective membrane pores larger than 500 Da occur.